REG - IQE PLC - IQE plc: Results of General Meeting

IqeAnnouncement

Yesterday 12:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260515:nRSO5681Ea&default-theme=true

RNS Number : 5681E  IQE PLC  15 May 2026

IQE plc

 

 

Cardiff, UK

15 May 2026

 

 

Results of General Meeting

 

 

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading global supplier of
compound semiconductor wafer products and advanced material solutions, is
pleased to announce that at its General Meeting, held today in London, all
resolutions were duly passed on a poll.  Resolution 1 was passed as an
ordinary resolution and Resolution 2 was passed as a special resolution.

Resolution 1: To generally and unconditionally authorise the Directors to
allot shares

For: 240,071,483 (99.27%)

Against: 1,776,099 (0.73%)

Withheld: 304,033

Total votes cast: 241,847,582

Resolution 2: To empower the Directors with additional rights to issue and
allot equity securities

For: 239,707,394 (99.18%)

Against: 1,975,745 (0.82%)

Withheld: 468,476

Total votes cast: 241,683,139

The full text of each resolution is available in the Circular and Notice of
General Meeting, published on 29 April 2026 and available on the Company's
website.

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Jutta Meier

Mark Cubitt

Amy Barlow

 

 

 

 

Peel Hunt (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Ben Cryer

Kate Bannatyne

Adam Telling

 

Deutsche Numis (Joint Broker)

+44 (0) 20 7260 1000

Hugo Rubinstein

Iqra Amin

 

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

 

ABOUT IQE

http://iqep.com
(https://www.globenewswire.com/Tracker?data=yZf7NKp1JKLALUCxlBuC8wkLnLAqoe5-kjjIlkMIDci9q9W0x_02bwZV-eorSbpLXZxy4zi3xHh-O4FM8nWjeg==)

 

 

IQE is the leading global supplier of advanced compound semiconductor wafers
and materials solutions that enable a diverse range of applications across:

 

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in
this market which has high barriers to entry. IQE supplies the global market
and is enabling customers to innovate at chip and OEM level. By leveraging the
Group's intellectual property portfolio including know-how and patents, it
produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across manufacturing
locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in
London.

 

 

IMPORTANT NOTICES

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United
Kingdom by the Financial Conduct Authority, is acting exclusively for IQE as
sole bookrunner, Nomad and joint broker and for no one else in connection with
the Proposed Fundraising and will not regard any other person (whether or not
a recipient of this announcement) as a client in relation to the Proposed
Fundraising or any other matter referred to in this announcement and will not
be responsible to anyone other than IQE for providing the protections afforded
to clients of Peel Hunt nor for providing advice in relation to the matters
set out in this announcement. Neither Peel Hunt nor any of its affiliates owes
or accepts any duty, liability or responsibility whatsoever (whether direct or
indirect, whether in contract, in tort, under statute or otherwise) to any
person who is not a client of Peel Hunt in connection with this announcement,
any statement contained herein or otherwise and no representation or warranty,
express or implied, is made by Peel Hunt with respect to the accuracy or
completeness of this announcement, or any part of it. Peel Hunt's
responsibilities as the Company's nominated adviser and broker under the AIM
Rules for Nominated Advisers are owed solely to the London Stock Exchange and
are not owed to the Company or to any Director or to any other person in
respect of the Proposed Fundraising.

Neither this announcement, nor any copy of it, may be taken or transmitted,
published or distributed, directly or indirectly, in or into the United States
(including its territories and dependencies, any state of the United States
and the District of Columbia), Australia, Canada, Japan, New Zealand or the
Republic of South Africa or to any persons in any of those jurisdictions or
any other jurisdiction where to do so would constitute a violation of the
relevant securities laws of such jurisdiction. This announcement is for
information purposes only and does not constitute an offer to sell or issue,
or the solicitation of an offer to buy, acquire or subscribe for any shares in
the capital of the Company in the United States, Australia, Canada, Japan or
the Republic of South Africa or any other state or jurisdiction in which such
offer or solicitation is not authorised or to any person to whom it is
unlawful to make such offer or solicitation.  Any failure to comply with
these restrictions may constitute a violation of securities laws of such
jurisdictions.

This announcement is not being distributed by, nor has it been approved for
the purposes of section 21 of the Financial Services and Markets Act 2000, as
amended ("FSMA"), by a person authorised under FSMA. This announcement is
being distributed to persons in the United Kingdom only in circumstances in
which section 21(1) of FSMA does not apply.

Neither the content of IQE's website (or any other website) nor the content of
any website accessible from hyperlinks on the Company's website (or any other
website) is incorporated into, or forms part of, this announcement.

Neither the information nor any opinion contained in this announcement
constitutes an inducement or offer to purchase or sell or a solicitation of an
offer to purchase or sell any securities or other investments in IQE or any
other company by IQE or any of its affiliates in any jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMAKPBDDBKDDPD



            Copyright 2019 Regulatory News Service, all rights reserved